Testing effectiveness (Phase 2)Study completedNCT02404441
What this trial is testing
Phase I/II Study of PDR001 in Patients With Advanced Malignancies
Who this might be right for
MelanomaNon-small Sell Lung Cancer (NSCLC)Triple Negative Breast Cancer+2 more
Novartis Pharmaceuticals 319